MENU
Advertisement
With commentary from Michael P. Thompson, PhD
Reprints
View Supplement
COAPT 5-Year Data Demonstrate Benefits of Mitral TEER, Reveal Need to Address Underlying LV Dysfunction
With commentary from Gregg Stone, MD
left-arrow Created with Sketch. Previous Article
Renal Denervation: Where We Stand After the FDA Panels
With Ajay J. Kirtane, MD, SM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI, FSVM; and Taisei Kobayashi, MD
Next Article right-arrow Created with Sketch.
Modern Clinical Trials Spotlight
Insights on current trial designs, inclusivity, and next steps.
View Issue
enVast™: Engineered for Coronary Thrombectomy
By Marco Valgimigli, MD, PhD
AeroShield™ Elite: Passive Protection Without Compromise
By William Gray, MD
When and How to Escalate MCS in Cardiogenic Shock
By Jessica Maria Gonzalez, MD, and Aditya Bharadwaj, MD
Operationalizing Radiation Safety in Cardiovascular Programs
By Denise Busman, MSN, RN, CPHQ, FACC
Modern Valve Intervention Workflows: Maintaining Efficiency Across Applications and Indications
With Mazen Albaghdadi, MD, MSc, and Natalia C. Berry, MD, MBA
